| dc.contributor.author | Samanci, N | |
| dc.contributor.author | Dagoglu, T | |
| dc.contributor.author | Ermis, B | |
| dc.contributor.author | Akdogan, Z | |
| dc.contributor.author | Ovali, F | |
| dc.date.accessioned | 2021-03-04T12:32:32Z | |
| dc.date.available | 2021-03-04T12:32:32Z | |
| dc.date.issued | 1998 | |
| dc.identifier.citation | Ovali F., Samanci N., Ermis B., Akdogan Z., Dagoglu T., "Alternative therapies for neonatal autoimmune thrombocytopenia", VOX SANGUINIS, cilt.74, sa.3, ss.198-200, 1998 | |
| dc.identifier.issn | 0042-9007 | |
| dc.identifier.other | av_77d571c8-34fa-40b5-89aa-7b961f860540 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/82239 | |
| dc.identifier.uri | https://doi.org/10.1159/000030931 | |
| dc.description.abstract | Objective: This study was performed to test whether corticosteroids were superior to intravenous immunoglobulins (IVIG) in the treatment of neonatal autoimmune thrombocytopenia (NAT). Methods: All cases received IVIG, and unresponsive cases received corticosteroids. Results: Of 7 babies who received IVIG, only 1 responded. The 6 remaining cases received corticosteroids thereafter, and all of them responded well to this therapy. Conclusions: Corticosteroids may be more effective than IVIG in NAT. | |
| dc.language.iso | eng | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Hematoloji | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | HEMATOLOJİ | |
| dc.title | Alternative therapies for neonatal autoimmune thrombocytopenia | |
| dc.type | Makale | |
| dc.relation.journal | VOX SANGUINIS | |
| dc.contributor.department | , , | |
| dc.identifier.volume | 74 | |
| dc.identifier.issue | 3 | |
| dc.identifier.startpage | 198 | |
| dc.identifier.endpage | 200 | |
| dc.contributor.firstauthorID | 119960 | |
